Lifecore Biomedical, Inc.

Contributing Author

Recent Articles by Lifecore Biomedical, Inc.

Jul-15	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LFCR +5.42% GlobeNewswire
Jun-15	Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company LFCR GlobeNewswire
Jun-02	Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer LFCR +12.37% GlobeNewswire
May-21	Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference LFCR +8.97% GlobeNewswire
May-12	Lifecore Biomedical to Participate at CDMO Live Europe LFCR GlobeNewswire
May-06	Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update LFCR GlobeNewswire
Apr-29	Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 LFCR GlobeNewswire
Apr-22	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LFCR LFCR -5.93% GlobeNewswire
Apr-08	Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit LFCR GlobeNewswire
Mar-26	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LFCR -7.64% LFCR -5.43% GlobeNewswire
Mar-26	Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer LFCR -7.64% GlobeNewswire
Mar-23	Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company LFCR GlobeNewswire
Mar-16	Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update LFCR -33.26% GlobeNewswire
Mar-10	Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum LFCR GlobeNewswire
Mar-09	Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 LFCR GlobeNewswire
Mar-04	Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment LFCR GlobeNewswire
Feb-17	Lifecore Biomedical to Participate at DCAT Week 2026 LFCR GlobeNewswire
Jan-16	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) LFCR GlobeNewswire
Dec-18	Lifecore Biomedical to be Added to Nasdaq Biotech Index LFCR GlobeNewswire
Dec-17	Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer LFCR +9.86% GlobeNewswire
Dec-16	Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference LFCR GlobeNewswire
Nov-11	Lifecore Biomedical to Participate in Upcoming Investor Conferences LFCR +6.17% LFCR +6.20% GlobeNewswire
Nov-06	Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update LFCR GlobeNewswire
Oct-30	Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 LFCR GlobeNewswire
Oct-29	Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company LFCR GlobeNewswire
Oct-13	Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events LFCR GlobeNewswire
Sep-23	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LFCR LFCR -10.70% GlobeNewswire
Sep-04	Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference LFCR LFCR -5.16% GlobeNewswire
Sep-02	Lifecore Biomedical to Participate in Upcoming Investor Conferences LFCR GlobeNewswire
Aug-07	Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update LFCR LFCR -6.70% GlobeNewswire
Jul-31	Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 LFCR GlobeNewswire
Jul-17	Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) LFCR GlobeNewswire
Jun-17	Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer LFCR GlobeNewswire
Jun-12	Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale LFCR GlobeNewswire
May-27	Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer LFCR GlobeNewswire

Lifecore Biomedical, Inc.

Recent Articles by Lifecore Biomedical, Inc.

Upgrade your Finviz experience